- New Cystic Fibrosis Drug — WVU Health Report
- DEA Targets Gas Station, Jeweler in 29-State Synthetic Drug Sweep – Los Angeles Times
- News in Brief: ADA Father of the Year Awards Announced
- Elk County Jail Experiences Overcrowding
- Are There Any Doctors in Michigan Who Prescribe Methadone for Addiction?
- Defibrillator After Heart Attack? What Does That Mean?
- Residential Psychiatric Treatment for Young Adults in New England?
- Addiction Treatment Center
- Prescription Drug Abuse a Problem – San Angelo Standard Times
- Drug Rehab Centers Howard County Call 410-777-5692 for Help Now MD
- Who’s Know About Drug Addiction?
- Addiction in the Heartland, How Drugs and Alcohol Are Poisoning Our Youth
- Prescription Drug Abuse a Problem – San Angelo Standard Times
Temporary Tattoos May Put You at Risk
Temporary Tattoos May Put You at Risk
Filed under: drug treatment programs maryland
SILVER SPRING, Md., May 22, 2013 /PRNewswire-USNewswire/ — Spring break and summer vacation are around the corner … time to pack your swim suit, hit the beach, and perhaps indulge in a little harmless fun. What about … If you have a reaction to or …
Read more on Wall Street Journal (press release)
Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of US Phase 2 …
Filed under: drug treatment programs maryland
The Principal Investigator is Dr. Devalingam Mahalingam, M.D., Ph.D., MRCP(UK), MRCP(I), clinical investigator in GI/thoracic oncology and drug development at the Cancer Therapy & Research Center at the University of Texas Health Science Center (CTRC …
Read more on Canada NewsWire (press release)
Costs to treat stroke in America may double by 2030
Filed under: drug treatment programs maryland
Stroke prevalence is projected to increase the most among Hispanic men between now and 2030, and the cost of treating stroke in Hispanic women is expected to triple. “Strokes will absolutely strain the healthcare system,” said Bruce Ovbiagele, M.D., M …
Read more on WebWire (press release)
Boston Scientific Announces Results from Promus Premier, Synergy Drug …
Filed under: drug treatment programs maryland
Boston Scientific Corporation (NYSE: BSX) reports positive results from two trials evaluating new, innovative drug-eluting stent (DES) technologies, which are emerging treatment options for coronary heart disease. … data from the EVOLVE Trial …
Read more on Benzinga